Viewing Study NCT00503594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-01-28 @ 4:59 PM
Study NCT ID: NCT00503594
Status: UNKNOWN
Last Update Posted: 2012-07-30
First Post: 2007-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary central nervous system lymphoma View
None Brain lymphoma View
None Elderly View
None Chemotherapy View
None Methotrexate View
None Temozolomide View
None Procarbazine View
None Vincristine View
None Cytarabine View